Comments
Loading...
Heron Therapeutics Stock Guidance | NASDAQ:HRTX | Benzinga
Heron Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | HRTX | Heron Therapeutics | FY | 2025 | — | — | — | $153.00M | $163.00M | $160.63M | Get Alert |
| 11/12/2024 | HRTX | Heron Therapeutics | Q4 | 2024 | — | — | — | $37.00M | $43.00M | $40.73M | Get Alert |
| 11/12/2024 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $140.00M | $146.00M | $148.40M | Get Alert |
| 08/06/2024 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $147.85M | Get Alert |
| 05/07/2024 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $144.87M | Get Alert |
| 03/12/2024 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $139.10M | Get Alert |
| 11/14/2023 | HRTX | Heron Therapeutics | FY | 2023 | — | — | — | $123.00M | $125.00M | $124.61M | Get Alert |
| 11/14/2023 | HRTX | Heron Therapeutics | FY | 2024 | — | — | — | $138.00M | $158.00M | $156.57M | Get Alert |
| 11/08/2022 | HRTX | Heron Therapeutics | FY | 2022 | — | — | — | $93.00M | $95.00M | $107.14M | Get Alert |
| 08/09/2022 | HRTX | Heron Therapeutics | FY | 2022 | — | — | — | $93.00M | $95.00M | $106.69M | Get Alert |
FAQ
What is the most recent guidance for Heron Therapeutics (HRTX)?
There have been no specific sales or earnings guidance reported for Heron Therapeutics in recent months.
Browse guidance and forecast on all stocks.
